(en) M. Taylor, K. Mackay, J. Murphy, A. McIntosh, C. McIntosh, S. Anderson et K. Welch, «Quantifying the RR of harm to self and others from substance misuse: results from a survey of clinical experts across Scotland», BMJ Open, vol.2, no4, , e000774–e000774 (DOI10.1136/bmjopen-2011-000774, lire en ligne, consulté le )
Dunlap LE, Andrews AM & Olson DE «Dark classics in chemical neuroscience: 3,4-methylenedioxymethamphetamine» ACS Chem Neurosci. 2018;9(10):2408-2427. https://doi.org/10.1021/acschemneuro.8b00155
Renton RJ, Cowie JS & Oon MCH «A study of the precursors, intermediates and reaction by-products in the synthesis of 3,4-methylenedioxymethylamphetamine and its application to forensic drug analysis» Forensic Sci Internat. 1993;60(3):189-202. https://doi.org/10.1016/0379-0738(93)90238-6
Palhol F et al. «Impurity profiling of seized MDMA tablets by capillary gas chromatography» Anal Bioanal Chem. 2002;374(2):274–281. https://doi.org/10.1007/s00216-002-1477-6
Milhazes N et al. «Electrochemical and spectroscopic characterisation of amphetamine-like drugs: Application to the screening of 3,4-methylenedioxymethamphetamine (MDMA) and its synthetic precursors» Anal Chim Acta 2007;596(2):231-241. https://doi.org/10.1016/j.aca.2007.06.027
Gimeno P et al. «A study of impurities in intermediates and 3,4-methylenedioxymethamphetamine (MDMA) samples produced via reductive amination routes» Forensic Sci Internat. 2005;155(2-3):141-157. https://doi.org/10.1016/j.forsciint.2004.11.013
Gallagher R, Shimmon R & McDonagh AM «Synthesis and impurity profiling of MDMA prepared from commonly available starting materials» Forensic Sci Internat. 2012;223(1-3):306-313. https://doi.org/10.1016/j.forsciint.2012.10.006
Braun U, Shulgin AT & Braun G «Centrally active N-substituted analogs of 3,4-methylenedioxyphenylisopropylamine (3,4-methylenedioxyamphetamine)» J Phar Sci. 1980;69(2):192-195. https://doi.org/10.1002/jps.2600690220
Heather E, Shimmon R & McDonagh A «Organic impurity profiling of 3,4-methylenedioxymethamphetamine (MDMA) synthesised from catechol and eugenol via 4-allylcatechol» Forensic Sci Internat. 2020;309:110176. https://doi.org/10.1016/j.forsciint.2020.110176
Parker MA et al. «Synthesis and Pharmacological Evaluation of Ring-Methylated Derivatives of 3,4-(Methylenedioxy)amphetamine (MDA)» J Med Chem. 1998;41(6):1001-1005. https://doi.org/10.1021/jm9705925
(en) S. Snelders et T. Pieters, «Speed in the Third Reich: Metamphetamine (Pervitin) Use and a Drug History From Below», Social History of Medicine, vol.24, no3, , p.686–699 (ISSN0951-631X et 1477-4666, DOI10.1093/shm/hkq101, lire en ligne, consulté le ).
Theodoridou A, Rowe AC, Penton-Voak IS, Rogers PJ, «Oxytocin and social perception: oxytocin increases perceived facial trustworthiness and attractiveness», Horm Behav, vol.56, no1, , p.128–32 (PMID19344725, DOI10.1016/j.yhbeh.2009.03.019).
S. Parker Singleton, Julie B. Wang, Michael Mithoefer et Colleen Hanlon, «Altered brain activity and functional connectivity after MDMA-assisted therapy for post-traumatic stress disorder», Frontiers in Psychiatry, vol.13, (ISSN1664-0640, DOI10.3389/fpsyt.2022.947622/full, lire en ligne, consulté le ).
(en) M. Taylor, K. Mackay, J. Murphy, A. McIntosh, C. McIntosh, S. Anderson et K. Welch, «Quantifying the RR of harm to self and others from substance misuse: results from a survey of clinical experts across Scotland», BMJ Open, vol.2, no4, , e000774–e000774 (DOI10.1136/bmjopen-2011-000774, lire en ligne, consulté le )
George Hatzidimitriou, Una D. McCann et George A. Ricaurte, «Altered Serotonin Innervation Patterns in the Forebrain of Monkeys Treated with (±)3,4-Methylenedioxymethamphetamine Seven Years Previously: Factors Influencing Abnormal Recovery», The Journal of Neuroscience, vol.19, no12, , p.5096–5107 (ISSN0270-6474, PMID10366642, PMCID6782677, DOI10.1523/JNEUROSCI.19-12-05096.1999, lire en ligne, consulté le )
Liechti, M., Gamma, A. et Vollenweider, F., Psychopharmacology (2001) 154: 161, DOI10.1007/s002130000648.
(en) Valerie H. Curran, «Sub-acute effects of MDMA (±3,4-methylenedioxymethamphetamine, ecstasy) on mood: evidence of gender differences», Psychopharmacology, Springer, vol.161, no1, , p.23–31 (ISSN1432-2072, DOI10.1007/s00213-001-0995-9, lire en ligne, consulté le ).
S. Parker Singleton, Julie B. Wang, Michael Mithoefer et Colleen Hanlon, «Altered brain activity and functional connectivity after MDMA-assisted therapy for post-traumatic stress disorder», Frontiers in Psychiatry, vol.13, (ISSN1664-0640, DOI10.3389/fpsyt.2022.947622/full, lire en ligne, consulté le ).
S. Bernschneider-Reif, F. Oxler et R. W. Freudenmann, «The origin of MDMA ("ecstasy")--separating the facts from the myth», Die Pharmazie, vol.61, no11, , p.966–972 (ISSN0031-7144, PMID17152992, lire en ligne, consulté le ).
(en) S. Snelders et T. Pieters, «Speed in the Third Reich: Metamphetamine (Pervitin) Use and a Drug History From Below», Social History of Medicine, vol.24, no3, , p.686–699 (ISSN0951-631X et 1477-4666, DOI10.1093/shm/hkq101, lire en ligne, consulté le ).
S. Parker Singleton, Julie B. Wang, Michael Mithoefer et Colleen Hanlon, «Altered brain activity and functional connectivity after MDMA-assisted therapy for post-traumatic stress disorder», Frontiers in Psychiatry, vol.13, (ISSN1664-0640, DOI10.3389/fpsyt.2022.947622/full, lire en ligne, consulté le ).
George Hatzidimitriou, Una D. McCann et George A. Ricaurte, «Altered Serotonin Innervation Patterns in the Forebrain of Monkeys Treated with (±)3,4-Methylenedioxymethamphetamine Seven Years Previously: Factors Influencing Abnormal Recovery», The Journal of Neuroscience, vol.19, no12, , p.5096–5107 (ISSN0270-6474, PMID10366642, PMCID6782677, DOI10.1523/JNEUROSCI.19-12-05096.1999, lire en ligne, consulté le )
(en) Valerie H. Curran, «Sub-acute effects of MDMA (±3,4-methylenedioxymethamphetamine, ecstasy) on mood: evidence of gender differences», Psychopharmacology, Springer, vol.161, no1, , p.23–31 (ISSN1432-2072, DOI10.1007/s00213-001-0995-9, lire en ligne, consulté le ).
François Béguin, «L'ecstasy de retour dans le milieu festif: La consommation de cette drogue est à son niveau maximal depuis une décennie», Le Monde, (lire en ligne).
Doblin, Rick. A Clinical Plan for MDMA (Ecstasy) in the Treatment of Post-Traumatic Stress Disorder (PTSD): Partnering with the FDA. Referenced 2011-10-23 from http://www.maps.org/news-letters/v12n3/12305dob.html
(en) Benzenhöfer U, «The early history of ecstasy», Nevenartz, (lire en ligne)
S. Bernschneider-Reif, F. Oxler et R. W. Freudenmann, «The origin of MDMA ("ecstasy")--separating the facts from the myth», Die Pharmazie, vol.61, no11, , p.966–972 (ISSN0031-7144, PMID17152992, lire en ligne, consulté le ).
Theodoridou A, Rowe AC, Penton-Voak IS, Rogers PJ, «Oxytocin and social perception: oxytocin increases perceived facial trustworthiness and attractiveness», Horm Behav, vol.56, no1, , p.128–32 (PMID19344725, DOI10.1016/j.yhbeh.2009.03.019).
George Hatzidimitriou, Una D. McCann et George A. Ricaurte, «Altered Serotonin Innervation Patterns in the Forebrain of Monkeys Treated with (±)3,4-Methylenedioxymethamphetamine Seven Years Previously: Factors Influencing Abnormal Recovery», The Journal of Neuroscience, vol.19, no12, , p.5096–5107 (ISSN0270-6474, PMID10366642, PMCID6782677, DOI10.1523/JNEUROSCI.19-12-05096.1999, lire en ligne, consulté le )
pubmed.ncbi.nlm.nih.gov
S. Bernschneider-Reif, F. Oxler et R. W. Freudenmann, «The origin of MDMA ("ecstasy")--separating the facts from the myth», Die Pharmazie, vol.61, no11, , p.966–972 (ISSN0031-7144, PMID17152992, lire en ligne, consulté le ).
(en) Laurent Galineau, «Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) exposure induces long-term alterations in the dopaminergic and serotonergic functions in the rat», Brain research. Developmental brain research., , p.165-176 (lire en ligne).
(en) S. Snelders et T. Pieters, «Speed in the Third Reich: Metamphetamine (Pervitin) Use and a Drug History From Below», Social History of Medicine, vol.24, no3, , p.686–699 (ISSN0951-631X et 1477-4666, DOI10.1093/shm/hkq101, lire en ligne, consulté le ).
(en) Valerie H. Curran, «Sub-acute effects of MDMA (±3,4-methylenedioxymethamphetamine, ecstasy) on mood: evidence of gender differences», Psychopharmacology, Springer, vol.161, no1, , p.23–31 (ISSN1432-2072, DOI10.1007/s00213-001-0995-9, lire en ligne, consulté le ).
Amine Benyamina et Isabelle de Paillette (préf.professeur Michel Reynaud), Réponses à vos questions sur le cannabis et les autres drogues, Paris, Solar, , 197p. (ISBN978-2-263-03904-1, OCLC62609834).
(en) Yasmina Salmandjee, Les drogues: Tout savoir sur leurs effets, leurs risques et la législation, Eyrolles, coll.«Eyrolles Pratique», , 223p. (ISBN978-2-7081-3532-1, OCLC181336267)
